Krka, d. d. (LJSE:KRKG)

Slovenia flag Slovenia · Delayed Price · Currency is EUR
199.00
-8.00 (-3.86%)
At close: Oct 7, 2025
-3.86%
Market Cap6.32B
Revenue (ttm)1.97B
Net Income (ttm)380.92M
Shares Out30.54M
EPS (ttm)12.42
PE Ratio16.66
Forward PE16.13
Dividend8.25 (3.99%)
Ex-Dividend DateJul 22, 2025
Volume19,061
Average Volume9,899
Open205.00
Previous Close207.00
Day's Range197.00 - 205.00
52-Week Range133.00 - 225.00
Beta0.49
RSI29.51
Earnings DateNov 13, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 11,308
Stock Exchange Ljubljana Stock Exchange
Ticker Symbol KRKG
Full Company Profile

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial Statements

News

There is no news available yet.